Antifungal composition comprising fenpyrazamine and difenoconazole
A technology of difenoconazole and pyrafenone, which is applied in the direction of fungicides, biocides, biocides, etc., to achieve high bactericidal activity, reduce the number of application times and dosage, and achieve good therapeutic effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] 4% Amphetamine·Difenoconazole Microemulsion (1:1)
[0020] The composition of raw materials is 2% fenpyrafen, 2% difenoconazole, 5% N,N-dimethylformamide, 5% cyclohexanone, 10% heavy benzene, 5% phenylethyl Phenol formaldehyde resin polyoxyethylene ether, 2% calcium dodecylbenzene sulfonate, 7% alkylphenol polyoxyethylene ether, 5% ethylene glycol, the rest is made up with water, and prepared according to a conventional microemulsion method.
[0021] Field Trial 1:
[0022] The experimental medicament is 4% difenoconazole microemulsion of difenoconazole, prepared according to Example 1, and the control medicine is 30% difenoconazole suspension concentrate and 10% difenoconazole wettable powder; Control object, Botrytis cinerea;
[0023]
[0024]
[0025] The average temperature during application is 20-25°C, and the weather is mostly sunny to cloudy. The data show that compared with the single agent, the compound preparation has improved prevention efficiency an...
Embodiment 2
[0031] 8% Amphetamine·Difenoconazole EC (1:1)
[0032] Composition of raw materials: 4% fenpyrafen, 4% difenoconazole, 6% N,N-dimethylformamide, 10% acetone, 5% calcium dodecylbenzenesulfonate, 5% tristyrylphenol polyoxyethylene ether, 3% phenylethylphenol formaldehyde resin polyoxyethylene ether, and the rest is made up with heavy benzene. Formulated as conventional cream.
[0033] Field Trial 1:
[0034] The experimental medicament is 8% difenoconazole emulsifiable concentrate, prepared according to Example 2, and the contrast agent is 30% difenoconazole suspension concentrate and 10% difenoconazole wettable powder; Object, cucumber powdery mildew;
[0035]
[0036]
[0037] The average temperature during application is 20-25°C, and the weather is mostly sunny to cloudy. The data show that compared with the single agent, the compound preparation has improved prevention efficiency and obvious synergistic effect.
[0038] Field efficacy test 2:
[0039] The experime...
Embodiment 3
[0043] 10% Amphetamine·Difenoconazole Water Emulsion (4:1)
[0044] Composition of raw materials: 8% pyrafenone technical, 2% difenoconazole technical, 7% acetone, 13% xylene, 3% calcium dodecylbenzenesulfonate, 5% triphenylethylphenol Polyoxyethylene ether, 2% phenethylphenol formaldehyde resin polyoxyethylene ether, 8% anyylphenol polyoxyethylene ether, 5% ethylene glycol, and make up the rest with water. Formulated with conventional water and milk.
[0045] Field Trial 1:
[0046] Experimental medicament is 10% difenoconazole aqueous emulsion prepared according to embodiment 3, and contrast medicament is 30% difenoconazole suspension concentrate and 10% difenoconazole wettable powder; object, citrus anthracnose;
[0047]
[0048]The average temperature during application is 20-25°C, and the weather is mostly sunny to cloudy. The data show that compared with the single agent, the compound preparation has improved prevention efficiency and obvious synergistic effect.
...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com